Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +41.72%
#3 Glidr Glidr +35.94%
#4 Walrus Walrus +22.36%
#5 Tutorial Tutorial +21.99%
#6 Humanity Humanity +18.29%
#7 Codatta Codatta +15.82%
#8 Ribbita by Virtuals Ribbita by Virtuals +14.49%
#9 Cysic Cysic +14.17%
#10 Enso Enso +14.10%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cellular Goods PLC Cellular Goods PLC

Cellular Goods PLC

CBX
Clasificación en acciones #36861
Cellular Goods PLC, along with its associated companies, specializes in... Cellular Goods PLC, along with its associated companies, specializes in creating and distributing consumer products infused with biosynthetic cannabinoids throughout the United Kingdom. Their portfolio includes cannabinoid-based solutions designed for both skincare applications and oral consumption. These items are available for purchase via traditional retailers, directly to customers through their proprietary website, and across various online platforms. Established in 2018, the organization was originally named Leaf Studios PLC, subsequently adopting the Cellular Goods PLC moniker in September 2020, and maintains its headquarters in London, UK.
Precio por acción
$0.00447785
Última sincronización: 2024-03-12
Capitalización bursátil
$2.26M
Cambio (1 día)
7.54%
Cambio (1 año)
0.00%
País
GB
Comercio Cellular Goods PLC (CBX)

Categoría

Healthcare
Ingresos de Cellular Goods PLC (CBX)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Cellular Goods PLC, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Cellular Goods PLC desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US